Alliancebernstein L.P. Y M Abs Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 54,780 shares of YMAB stock, worth $446,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,780

Previous 58,140 5.78%

Holding current value

$446,457

Previous $702,000 2.42%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.95 - $15.39 $33,432 - $51,710	-3,360 Reduced 5.78%	54,780 $719,000
Q2 2024 Aug 14, 2024	SELL	$11.6 - $17.25 $43,848 - $65,205	-3,780 Reduced 6.1%	58,140 $702,000
Q1 2024 May 14, 2024	SELL	$6.57 - $18.69 $5,321 - $15,138	-810 Reduced 1.29%	61,920 $1.01 Million
Q4 2023 Feb 14, 2024	SELL	$4.88 - $7.42 $71,047 - $108,027	-14,559 Reduced 18.84%	62,730 $427,000
Q3 2023 Nov 14, 2023	SELL	$4.86 - $7.23 $435,942 - $648,531	-89,700 Reduced 53.72%	77,289 $421,000
Q2 2023 Aug 15, 2023	BUY	$5.68 - $10.34 $64,468 - $117,359	11,350 Added 7.29%	166,989 $1.13 Million
Q4 2022 Feb 14, 2023	SELL	$3.0 - $15.17 $5.98 Million - $30.3 Million	-1,994,425 Reduced 92.76%	155,639 $759,000
Q3 2022 Nov 15, 2022	SELL	$13.96 - $19.67 $9.29 Million - $13.1 Million	-665,801 Reduced 23.64%	2,150,064 $31 Million
Q2 2022 Aug 15, 2022	SELL	$8.22 - $15.13 $1.26 Million - $2.32 Million	-153,294 Reduced 5.16%	2,815,865 $42.6 Million
Q1 2022 May 13, 2022	BUY	$6.55 - $17.42 $6.73 Million - $17.9 Million	1,026,825 Added 52.87%	2,969,159 $35.3 Million
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $8.14 Million - $15.4 Million	524,525 Added 37.0%	1,942,334 $31.5 Million
Q3 2021 Nov 10, 2021	BUY	$27.47 - $37.31 $1.9 Million - $2.58 Million	69,213 Added 5.13%	1,417,809 $40.5 Million
Q2 2021 Jul 30, 2021	BUY	$25.45 - $37.64 $2.98 Million - $4.41 Million	117,258 Added 9.52%	1,348,596 $45.6 Million
Q1 2021 May 06, 2021	BUY	$29.16 - $51.96 $6.44 Million - $11.5 Million	221,019 Added 21.88%	1,231,338 $37.2 Million
Q4 2020 Feb 08, 2021	BUY	$37.86 - $54.26 $1.92 Million - $2.76 Million	50,803 Added 5.29%	1,010,319 $50 Million
Q3 2020 Nov 12, 2020	BUY	$35.13 - $43.62 $2.53 Million - $3.15 Million	72,119 Added 8.13%	959,516 $36.8 Million
Q2 2020 Aug 13, 2020	SELL	$23.66 - $49.53 $1.19 Million - $2.49 Million	-50,332 Reduced 5.37%	887,397 $38.3 Million
Q1 2020 May 14, 2020	BUY	$14.39 - $35.8 $1.34 Million - $3.34 Million	93,265 Added 11.04%	937,729 $24.5 Million
Q4 2019 Feb 18, 2020	BUY	$23.81 - $33.78 $1.88 Million - $2.66 Million	78,763 Added 10.29%	844,464 $26.4 Million
Q3 2019 Nov 14, 2019	BUY	$21.57 - $31.37 $464,747 - $675,898	21,546 Added 2.9%	765,701 $20 Million
Q2 2019 Aug 14, 2019	BUY	$19.51 - $28.31 $1.56 Million - $2.27 Million	80,149 Added 12.07%	744,155 $17 Million
Q1 2019 May 14, 2019	BUY	$18.21 - $26.21 $1.96 Million - $2.82 Million	107,668 Added 19.35%	664,006 $17.4 Million
Q4 2018 Feb 13, 2019	BUY	$15.41 - $28.92 $3.57 Million - $6.69 Million	231,348 Added 71.19%	556,338 $11.3 Million
Q3 2018 Nov 08, 2018	BUY	$24.0 - $26.97 $7.8 Million - $8.76 Million	324,990 New	324,990 $8.63 Million

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Y M Abs Therapeutics, Inc. Transaction History